Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Sars Cov 2
Type
Observational
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

This study aims to collect information on staff working at the Greifswald University hospital. Over a 5 year period, a maximum of 6 study visits per participant are planned. At each visit, nasal/throat swabs (for PCR testing) and/or blood samples (to assess immunological responses, e.g. for SARS-CoV...

This study aims to collect information on staff working at the Greifswald University hospital. Over a 5 year period, a maximum of 6 study visits per participant are planned. At each visit, nasal/throat swabs (for PCR testing) and/or blood samples (to assess immunological responses, e.g. for SARS-CoV-2 antibody testing) will be collected. This will help to gain a better understanding of viral load and immunological responses, e.g. antibody development and their effects over time. At study visit 2 - 6, participants will also be asked to fill in a questionnaire (asking for SARS-CoV-2 risk factors, perceived risk, impact of the pandemic on their quality of life, their interest in getting a SARS-CoV-2 vaccine/their SARS-CoV-2 vaccination status and vaccination side effects). The remaining blood samples will be stored in a repository for future research. The study is part of a modular SARS-CoV-2-research programme of the University Medicine Greifswald.

Tracking Information

NCT #
NCT04370119
Collaborators
  • Friedrich Loefler Institute for Animal Health
  • EUROIMMUN AG
Investigators
Principal Investigator: Nils-Olaf Hübner, Prof.Dr. University Medicine Greifswald Principal Investigator: Karsten Becker, Prof.Dr. University Medicine Greifswald